Ben Lv
Impact in
- Clinical Biochemistry top 10%
- Advanced Glycation End Products research
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune Response and Inflammation
Papers in
-
- Advanced Glycation End Products research 2
-
- Renal Diseases and Glomerulopathies 2
- Co-authors
- Fangping ChenLin LiJin LiuXinyu YangYiting TangXianzhong XiaoHaichao WangFan Zhang
- Journals
- International Immunopharmacology (2 papers)Scientific Reports (1 paper)RSC Advances (1 paper)Nature Communications (1 paper)Acta Biochimica et Biophysica Sinica (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Ben Lv
13 papers receiving 396 citations
Peers
Comparison fields: 5 of 90
- Clinical Biochemistry 52
- Immunology 134
- Critical Care and Intensive Care Medicine 19
- Nephrology 21
- Pharmacology 23
Countries citing papers authored by Ben Lv
This map shows the geographic impact of Ben Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Lv more than expected).
Fields of papers citing papers by Ben Lv
This network shows the impact of papers produced by Ben Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Lv. The network helps show where Ben Lv may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ben Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 28 | |
| 2 | 2018 | 17 | |
| 3 | 2017 | 23 | |
| 4 | 2017 | 79 | |
| 5 | 2015 | 31 | |
| 6 | Establishment of stable multiple myeloma cell line with overexpressed PDCD5 and its proapoptosis mechanism. | 2015 | 2 |
| 7 | 2015 | 95 | |
| 8 | 2015 | 15 | |
| 9 | 2015 | 5 | |
| 10 | 2009 | 4 | |
| 11 | 2009 | 6 | |
| 12 | 2009 | 69 | |
| 13 | 2008 | 27 |
About Ben Lv
Ben Lv is a scholar working on Clinical Biochemistry, Nephrology, Immunology, Immunology and Allergy and Cellular and Molecular Neuroscience, having authored 13 papers that have together received 401 indexed citations. Recurring topics across this work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers), Renal Diseases and Glomerulopathies (2 papers), Immune Response and Inflammation (2 papers), Neuropeptides and Animal Physiology (2 papers), Advanced Glycation End Products research (2 papers), Metabolomics and Mass Spectrometry Studies (1 paper), Machine Learning in Materials Science (1 paper) and Antiplatelet Therapy and Cardiovascular Diseases (1 paper). The work is most often cited by research in Clinical Biochemistry (52 citations), Immunology (134 citations), Critical Care and Intensive Care Medicine (19 citations), Nephrology (21 citations) and Pharmacology (23 citations). Ben Lv has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Fangping Chen, Lin Li, Jin Liu, Xinyu Yang, Yiting Tang, Xianzhong Xiao, Haichao Wang, Fan Zhang, Aiping Lü and Alex F. Chen. Their work appears in journals such as International Immunopharmacology, Scientific Reports, RSC Advances, Nature Communications and Acta Biochimica et Biophysica Sinica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.